PROVE-IT to IMPROVE-IT Why LDL-C Goals Still Matter in Post-ACS Patients

被引：4
作者：
Wright, R. Scott [1 ]
Murphy, Joseph [1 ,2 ]
机构：
[1] Mayo Clin, Div Cardiol, 200 First St SW,Gonda 5-477, Rochester, MN 55905 USA
[2] Mayo Clin, Sect Sci Publicat, Rochester, MN 55905 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 04期
关键词：
acute coronary syndrome; ezetimibe; lipid modifying therapy; secondary prevention; ACUTE CORONARY SYNDROMES; LOW-DENSITY-LIPOPROTEIN; REACTIVE PROTEIN; CHOLESTEROL; EZETIMIBE; OUTCOMES;
D O I：
10.1016/j.jacc.2015.11.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：362 / 364
页数：3
相关论文
共 13 条
  • [1] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
    Baigent, C.
    Blackwell, L.
    Emberson, J.
    Holland, L. E.
    Reith, C.
    Bhala, N.
    Peto, R.
    Barnes, E. H.
    Keech, A.
    Simes, J.
    Collins, R.
    [J]. LANCET, 2010, 376 (9753) : 1670 - 1681
  • [2] Comprehensive Cardiovascular Risk Factor Control Improves Survival The BARI 2D Trial
    Bittner, Vera
    Bertolet, Marnie
    Felix, Rafael Barraza
    Farkouh, Michael E.
    Goldberg, Suzanne
    Ramanathan, Kodangudi B.
    Redmon, J. Bruce
    Sperling, Laurence
    Rutter, Martin K.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (07) : 765 - 773
  • [3] Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT
    Bohula, Erin A.
    Giugliano, Robert P.
    Cannon, Christopher P.
    Zhou, Jing
    Murphy, Sabina A.
    White, Jennifer A.
    Tershakovec, Andrew M.
    Blazing, Michael A.
    Braunwald, Eugene
    [J]. CIRCULATION, 2015, 132 (13) : 1224 - 1233
  • [4] Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
    Cannon, Christopher P.
    Blazing, Michael A.
    Giugliano, Robert P.
    McCagg, Amy
    White, Jennifer A.
    Theroux, Pierre
    Darius, Harald
    Lewis, Basil S.
    Ophuis, Ton Oude
    Jukema, J. Wouter
    De Ferrari, Gaetano M.
    Ruzyllo, Witold
    De Lucca, Paul
    Im, KyungAh
    Bohula, Erin A.
    Reist, Craig
    Wiviott, Stephen D.
    Tershakovec, Andrew M.
    Musliner, Thomas A.
    Braunwald, Eugene
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) : 2387 - 2397
  • [5] Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease A Randomized Clinical Trial
    Chow, Clara K.
    Redfern, Julie
    Hillis, Graham S.
    Thakkar, Jay
    Santo, Karla
    Hackett, Maree L.
    Jan, Stephen
    Graves, Nicholas
    de Keizer, Laura
    Barry, Tony
    Bompoint, Severine
    Stepien, Sandrine
    Whittaker, Robyn
    Rodgers, Anthony
    Thiagalingam, Aravinda
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (12): : 1255 - 1263
  • [6] Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
    Libby, Peter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (21) : 2004 - 2013
  • [7] A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps
    Lopez-Jimenez, Francisco
    Simha, Vinaya
    Thomas, Randal J.
    Allison, Thomas G.
    Basu, Ananda
    Fernandes, Regis
    Hurst, R. Todd
    Kopecky, Stephen L.
    Kullo, Iftikhar J.
    Mulvagh, Sharon L.
    Thompson, Warren G.
    Trejo-Gutierrez, Jorge F.
    Wright, R. Scott
    [J]. MAYO CLINIC PROCEEDINGS, 2014, 89 (09) : 1257 - 1278
  • [8] Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial
    Morrow, David A.
    de Lemos, James A.
    Sabatine, Marc S.
    Wiviott, Stephen D.
    Blazing, Michael A.
    Shui, Amy
    Rifai, Nader
    Califf, Robert M.
    Braunwald, Eugene
    [J]. CIRCULATION, 2006, 114 (04) : 281 - 288
  • [9] Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome The IMPROVE-IT Trial
    Murphy, Sabina A.
    Cannon, Christopher P.
    Blazing, Michael A.
    Giugliano, Robert P.
    White, Jennifer A.
    Lokhnygina, Yuliya
    Reist, Craig
    Im, KyungAh
    Bohula, Erin A.
    Isaza, Daniel
    Lopez-Sendon, Jose
    Dellborg, Mikael
    Kher, Uma
    Tershakovec, Andrew M.
    Braunwald, Eugene
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (04) : 353 - 361
  • [10] Optimal low-density lipoprotein is 50 to 70 mg/dl - Lower is better and physiologically normal
    O'Keefe, JH
    Cordain, L
    Harris, WH
    Moe, RM
    Vogel, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (11) : 2142 - 2146
12